The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
SARS: prognosis, outcome and sequelae
Open accessAbstract
Severe acute respiratory syndrome (SARS) is associated with considerable morbidity and mortality in the acute phase. Worldwide case fatality rate is 11% (range 7 to 27%) for the most severely affected regions. Several adverse prognostic factors have been identified, including advanced age, presence of comorbidity, higher lactose dehydrogenase levels and initial neutrophil count, but the impact of viral and other host factors on outcome is unknown. Published data on sequelae of SARS are limited. Clinical follow‐up of patients who recovered from SARS has demonstrated radiological, functional and psychological abnormalities of varying degrees. In the early rehabilitation phase, many complained of limitations in physical function from general weakness and/or shortness of breath. In a small series of subjects who underwent CT scan of the chest, over half showed some patchy changes consistent with pulmonary fibrosis. Lung function testing at 6–8 weeks after hospital discharge showed mild or moderate restrictive pattern consistent with muscle weakness in 6–20% of subjects. Mild decrease in carbon monoxide diffusing capacity was detected in a minority of subjects. Preliminary evidence suggests that these lung function abnormalities will improve over time. Psychobehavioural problems of anxiety and/or depression were not uncommon in the early recovery phase, and improved over time in the majority of patients. Avascular necrosis of the hip has been reported as another complication. The long‐term sequelae of SARS are still largely unknown. It is important to follow up these patients to detect and appropriately manage any persistent or emerging long‐term sequelae in the physical, psychological and social domains.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Major Outbreak of Severe Acute Respiratory Syndrome in Hong Kong
Lee, N., Hui, D., Wu, A., Chan, P., Cameron, P., Joynt, G. M., Ahuja, A., Yung, M. Y., Leung, C. B., To, K. F., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030685 · Cited by 2,628
Peiris, J., Chu, C., Cheng, V., Chan, K., Hung, I., Poon, L., Law, K., Tang, B., Hon, T., Chan, C., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13412-5 · Cited by 2,375
Self-citationClinical Features and Short-term Outcomes of 144 Patients With SARS in the Greater Toronto Area
Booth, C. M. (2003) · JAMA · doi:10.1001/jama.289.21.joc30885 · Cited by 1,406
Wong, R. S. M., Wu, A., To, K. F., Lee, N., Lam, C. W. K., Wong, C. K., Chan, P. K. S., Ng, M. H. L., Yu, L. M., Hui, D. S., et al. (2003) · BMJ · doi:10.1136/bmj.326.7403.1358 · Cited by 561
Lew, T. W. K. (2003) · JAMA · doi:10.1001/jama.290.3.374 · Cited by 426
Chan, J. W. M. (2003) · Thorax · doi:10.1136/thorax.58.8.686 · Cited by 394
Clinical presentations and outcome of severe acute respiratory syndrome in children
Hon, K., Leung, C., Cheng, W., Chan, P., Chu, W., Kwan, Y., Li, A., Fong, N., Ng, P., Chiu, M., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13364-8 · Cited by 389
Critically Ill Patients With Severe Acute Respiratory Syndrome
Fowler, R. A. (2003) · JAMA · doi:10.1001/jama.290.3.367 · Cited by 321
Antonio, G. E., Wong, K. T., Hui, D. S. C., Wu, A., Lee, N., Yuen, E. H. Y., Leung, C. B., Rainer, T. H., Cameron, P., Chung, S. S. C., et al. (2003) · Radiology · doi:10.1148/radiol.2283030726 · Cited by 290
Severe Acute Respiratory Syndrome: Clinical Outcome and Prognostic Correlates
Tsui, P. T., Kwok, M. L., Yuen, H., & Lai, S. T. (2003) · Emerging Infectious Diseases · doi:10.3201/eid0909.030362 · Cited by 220
Research works printed but not linked: 7
- Centres for Disease Control and Prevention. Update: severe acute respiratory syndrome—United States 2003.MMWRMorb. Mortal. Wkly Rep.2003;52:616.
- Hospital Authority of Hong Kong., 2003, Medical Services Development committee paper (MSDC‐P172) Clinical Management and outcome of SARS 25 August, 2003.
- 10.1097/01.PCC.0000077079.42302.81 · doi:10.1097/01.pcc.0000077079.42302.81
- Taam Wong V., 2003, Prognostic indicators and disease pattern. Proceeding of WHO workshop, July 13, 2003.
- SungJ.Clinical diagnosis and management of SARS. WHO workshop June 17–18 Malaysia. [Cited 29 August 2003.] Available from URL:http://www.who.int/csr/sars/conference/june_/materials/presentations/en/clinical_diagnosis.pdf
- ZhengJP WangHY AnJYet al.Pulmonary function in the rehabilitation period of severe acute respiratory syndome (SARS).Chin J Tuberc Respir Dis2003; in press.
- LiuY‐N.Severe acute respiratory syndrome: diagnosis treatment and follow up.Chinese Medical Forum 2nd Conference 8–12 September 2003 Beijing China.
Cited by
Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China
Li, B., Yang, J., Zhao, F., Zhi, L., Wang, X., Liu, L., Bi, Z., & Zhao, Y. (2020) · Clinical Research in Cardiology · doi:10.1007/s00392-020-01626-9 · Cited by 2,057
SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract
Hou, Y. J., Okuda, K., Edwards, C. E., Martinez, D. R., Asakura, T., Dinnon, K. H., Kato, T., Lee, R. E., Yount, B. L., Mascenik, T. M., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.042 · Cited by 1,488
The Severe Acute Respiratory Syndrome
Peiris, J. S. M., Yuen, K. Y., Osterhaus, A. D. M. E., & Stöhr, K. (2003) · New England Journal of Medicine · doi:10.1056/nejmra032498 · Cited by 1,346
Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection
Cheng, V. C. C., Lau, S. K. P., Woo, P. C. Y., & Yuen, K. Y. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00023-07 · Cited by 1,192
MERS, SARS and other coronaviruses as causes of pneumonia
Yin, Y., & Wunderink, R. G. (2018) · Respirology · doi:10.1111/resp.13196 · Cited by 1,095
Metadata
- Authors
- CHAN, K., ZHENG, J., Mok, Y., LI, Y., LIU, Y., CHU, C., & Ip, M.
- Venue
- Respirology
- Publisher
- Wiley
- Published
- 2003-11
- Volume
- 8
- Issue
- s1
- Pages
- S36-40
- ISSN
- 1323-7799 (ISSN-L)
- 1440-1843
- OpenAlex
- W1970860163
- Cited by
- 260
- References
- 10
- FWCI
- 4.89
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: SARS: prognosis, outcome and sequelae. https://app.cochat.ai/papers/10.1046/j.1440-1843.2003.00522.x
- The paper
- CHAN, K., ZHENG, J., Mok, Y., LI, Y., LIU, Y., CHU, C., & Ip, M. (2003). SARS: prognosis, outcome and sequelae. Respirology. https://doi.org/10.1046/j.1440-1843.2003.00522.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.